BioNTech
InstaDeep’s acquisition is a classic case of an African startup gone global
This January, Germany’s largest vaccine maker BioNTech announced that it had agreed to acquire Tunisian-born and London-headquartered AI startup InstaDeep for up to £562 million, including a perfor
BioNTech acquires Tunisian-born and UK-based AI startup InstaDeep for £562M
German-based biotech company BioNTech SE is set to acquire InstaDeep, a Tunis-born and U.K.-based artificial intelligence (AI) startup, for up to £562 million (~$680 million) in its largest deal yet.
Moderna sues Pfizer, BioNTech over alleged mRNA patent infringement
Moderna filed a lawsuit against Pfizer and BioNTech claiming the biopharmaceutical companies infringed on Moderna’s patents related to mRNA technology in development of their COVID-19 vaccine. The l
Tunisian enterprise AI startup InstaDeep raises $100M from AI Capital, BioNTech, Google
A recent survey carried out by CNBC reported that 81% of executives worldwide say AI will play a prominent and critical role in how their businesses operate this year. Companies are phasing from the f
For BioNTech, the COVID-19 vaccine was simply the opening act
Ultimately, BioNTech's mission is to make treatments that are optimized not only to specific patient needs, but also to time and place.
FDA fully approves Pfizer-BioNTech’s COVID-19 vaccine
The U.S. Food and Drug Administration (FDA) has granted full approval to Pfizer-BioNTech’s COVID-19 vaccine, making it the first vaccine to achieve that status. The mRNA-based vaccine has been a
BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt
It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer behind the world’s most widely-used COVID-19 v
Early bird savings on passes to TechCrunch Disrupt 2021 end this week
Tick tock, early-stage startup fans: If you plan to attend TechCrunch Disrupt 2021 (September 21-23), time is running out to score a pass to the world’s leading conference dedicated to tech startups
Pfizer-BioNTech’s COVID-19 vaccine just got a lot easier to transport and distribute
The COVID-19 vaccine developed by Pfizer and BioNTech now has less stringent and extreme transportation requirements than when it debuted. Originally, the mRNA-based vaccine had to be maintained at ul
Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data
Another COVID-19 vaccine is almost ready to begin being distributed — a single-shot inoculation made by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary. The company just release
Moderna says it’s making variant-specific COVID-19 vaccines, but its existing vaccine should still work
Moderna has detailed some of the steps it’s taking to ensure that its vaccine remains effective in the face of emerging strains of the SARS-CoV-2 virus that leads to COVID-19. These include test
FDA authorizes Moderna’s COVID-19 vaccine for emergency use
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, as expected after an independent panel commissioned by the administrat
FDA grants emergency use authorization for Pfizer’s COVID-19 vaccine, distribution to begin within days
The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the COVID-19 vaccine developed by Pfizer and its partner BioNTech, the New York Times first reported on
FDA panel recommends approving Pfizer’s COVID-19 vaccine emergency use authorization
An independent panel of experts has recommended the Food and Drug Administration (FDA) approve an official Emergency Use Authorization (EUA) for the Pfizer and BioNTech COVID-19 vaccine. This means th
Google to add COVID-19 vaccine information panels to Search
Google announced today it’s introducing a new search feature that will surface a list of authorized vaccines in users’ locations, as well as informational panels about each individual vacc
The UK approves the BioNTech/Pfizer COVID-19 vaccine for emergency use
The UK government has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, following the recommendation of the national medicines regulator. The UK is the first country to approve
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from
Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today
Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative tre
Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis
Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 va
Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial
Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says that it